Free LASIK for Professional Referees Across the NFL, NBA, MLB, NHL, MLS, USNT, WNBA, and NWSL

May 17, 2024 1:00 PM

The LASIK.com Network is excited to announce their "Better Vision, Better Calls" initiative to offer free Modern LASIK eye surgery for referees across the NFL, NBA, MLB, NHL, MLS, USNT, WNBA, and NWSL.CINCINNATI, OH / ACCESSWIRE / May 17, 2024 / In a move sure to catch the eyes of sports fans and officials alike, the LASIK.com Network of Trusted LASIK Doctors is thrilled to announce its groundbreaking initiative: offering professional league...

Read more

Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand

May 17, 2024 10:15 AM

CHICAGO, IL / ACCESSWIRE / May 17, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today its successful participation in Vitafoods Europe 2024, the world's leading...

Read more

Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

May 17, 2024 8:30 AM

SAN DIEGO, CA / ACCESSWIRE / May 17, 2024 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 516,336 shares of the Company's common stock, having...

Read more

Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024

May 17, 2024 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced that they will be presenting data from its Phase 2 trial evaluating Amiselimod as treatment for active ulcerative colitis (UC). The data will be presented at Digestive Disease Week (DDW) 2024 during the IMIBD Late Breakers and Innovations in IBD session on Sunday, May 19, 2024, in Washington, D.C."We are pleased to...

Read more

Senzime Appoints Former Dräger Medical CEO Wolfgang Reim as New Senior Advisor to The Board

May 17, 2024 2:45 AM

UPPSALA, SE / ACCESSWIRE / May 17, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in perioperative precision-based patient monitoring solutions, today announced the appointment of Dr. Wolfgang Reim as new senior advisor to its Board of Directors.Wolfgang Reim has a long medical industry career including positions as CEO of the Ultrasound Division of Siemens Healthcare, CEO of Dräger Medical during 2000-2006, and many Board...

Read more

The Exercise Period for Spago Nanomedical's Warrants of Series TO12 Commences Today

May 17, 2024 2:20 AM

LUND, SE / ACCESSWIRE / May 17, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) ("Spago Nanomedical" or the "Company") issued a total of 127,321,212 warrants of series TO12 ("Warrants") within the framework of a rights issue of units during the fourth quarter of 2023. The exercise period for the Warrants commences today, on May 17, 2024, and continues until May 30, 2024. One (1) Warrant entitles the holder to...

Read more

Governor Mike DeWine Launches New 'Children's Vision Strike Force' at Vision to Learn School Site

May 16, 2024 6:15 PM

Governor visits Vision To Learn efforts at Oxford Elementary in East ClevelandCLEVELAND, OH / ACCESSWIRE / May 16, 2024 / Governor Mike DeWine made history today by launching the first-ever statewide plan to ensure every child who needs glasses at school gets glasses. DeWine outlined the goals of his "Children's Vision Strike Force" during a visit to a school site served by Vision To Learn, the nation's largest charitable provider of mobile...

Read more

Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity

May 16, 2024 4:05 PM

Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of $11 million or approximately 80% of its existing debt with entities affiliated with CRG Partners III L.P. ("CRG") into a shares of a new series of convertible preferred stock.Following the conversion,...

Read more

ZetrOZ Systems to Showcase Wearable Ultrasound Unit at Premier College Athletic Trainers Conference

May 16, 2024 3:25 PM

Inventors of sustained acoustic medicine will present the FDA-cleared device for soft tissue healing at the CATS 2024 Symposium in Las Vegas on May 15-18. TRUMBULL, CT / ACCESSWIRE / May 16, 2024 / ZetrOZ Systems, the inventor of sustained acoustic medicine, will attend the College Athletic Trainers' Society (CATS) 2024 Symposium to showcase its sam® wearable ultrasound unit, a pioneering device for injury healing. ZetrOZ Systems will be at...

Read more

Orlance Announces Strategic Collaboration With Product Creation Studio for the Development of the MACH-1 System

May 16, 2024 1:00 PM

This Collaboration is Focused on Advancing the Design of the MACH-1 System, Preparing It for Phase 1 Clinical TrialsSEATTLE, WA / ACCESSWIRE / May 16, 2024 / Orlance, a pioneering Seattle-based biotech company, is thrilled to announce a new development project with esteemed partner Product Creation Studio (PCS), a leader in innovative engineering and design services. This collaboration is focused on advancing the design of the MACH-1 system,...

Read more

Third Party Withdraws Appeal Related to Cantargia Patent

May 16, 2024 11:15 AM

LUND, SWEDEN / ACCESSWIRE / May 16, 2024 / Cantargia (STO:CANTA) (Cantargia AB; Nasdaq Stockholm: CANTA) today reported that the Notice of Appeal filed with respect to one of Cantargia's granted European patents, EP3020730, has been withdrawn. Thereby, the patent remains in force with claims encompassing treatment of solid tumours by anti-IL1RAP-targeting antibody, as originally decided by the EPO Opposition Division."We are happy that our...

Read more

Communique from Annual General Meeting in Senzime AB (publ)

May 16, 2024 10:15 AM

UPPSALA, SWEDEN / ACCESSWIRE / May 16, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 16 May 2024 by at Advokatfirman Lindahl's premises on Vaksalagatan 10, Uppsala, whereby the shareholders primarily resolved on the following matters. All decisions were made with the required majority.Annual report and resultsThe annual general meeting adopted the...

Read more

Cyduct Diagnostics To Participate at the 10th Annual Yale Innovation Summit

May 16, 2024 10:00 AM

WESTPORT, CT / ACCESSWIRE / May 16, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", "CYductDX", or the "Company"), an innovator in precision breast health enabled by non-invasive intraductal platforms, today announced it is pleased to present at the 2024 Yale Innovation Summit, being held from May 29-30 in New Haven, CT. The 10th annual event will feature industry-leading speakers from the arts, biotech, climate, health, and...

Read more

CLS Health Announces Merger With Cardiac Rhythm Center

May 16, 2024 9:30 AM

The expansion adds cardiac electrophysiology to cardiac care services and extends the healthcare company's presence in the Houston area.HOUSTON, TX / ACCESSWIRE / May 16, 2024 / CLS Health, a leading physician-owned healthcare group, is proud to announce its strategic merger with the Cardiac Rhythm Center, a prominent provider of heart rhythm disorder treatments established in 2021. This merger significantly enhances CLS Health's cardiac care...

Read more

HealthJoy Leader Authors First-of-Its-Kind Book on Brain-Body Connection

May 16, 2024 9:00 AM

HealthJoy's Brian Astrachan Publishes 'Chronic Lower Back Pain Relief Through The Brain-Body Sync'CHICAGO, IL / ACCESSWIRE / May 16, 2024 / HealthJoy, a care navigation platform that transforms healthcare outcomes, announced today that Brian Astrachan, General Manager, MSK at HealthJoy, recently published his first book, "Chronic Lower Back Pain Relief Through The Brain-Body Sync."The publication is the first of its kind to outline the...

Read more

Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2024

May 16, 2024 9:00 AM

BIOPROCESSING REVENUES INCREASE 42% FIRST MULTI-PARAMETER SENSOR ("MPS") PRODUCTS SHIPPED IN APRILInvestor Call to be held Thursday, May 16th at 11:00 a.m. Eastern TimeBOHEMIA, NY / ACCESSWIRE / May 16, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, yesterday reported financial results for the three-month period ended March 31, 2024.Business...

Read more

Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024

May 16, 2024 9:00 AM

NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation of advanced pharmaceuticals through novel 3D screen-printing platform technology SPID®, announced today its participation in the 2024 BIO International Convention on June 3-6, 2024 in San Diego, CA. The Company will be showcasing its LXM.2 asset to potential partners.The BIO International Convention is the world's largest...

Read more

Bio Conscious Announces Strategic API Integration with Dexcom That Will Elevate the Current Level of Care for Diabetes Patients in Clinical Settings

May 16, 2024 9:00 AM

VANCOUVER, BC and HOUSTON, TX / ACCESSWIRE / May 16, 2024 / Bio Conscious Technologies Inc., a global leader at the intersection of Artificial Intelligence (AI) and Health Technology today announced a new API Integration with Dexcom, the global leader in real-time continuous glucose monitoring (CGM), that will securely integrate Dexcom CGM data with the AI-powered ARPM platform to Bio Conscious' Endobits.Dexcom CGM Users Now Have Access to...

Read more

NIKKI Wins Approval at Cellcore Exclusive ECO24 Event

May 16, 2024 8:30 AM

Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited to announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), was one of 40 companies presenting at the exclusive ECO24 Event held on May 2nd, 3rd and 4th in Dallas, Texas. ECO24 is an annual CellCore Biosciences Event with approximately 1,500 frequency and Lyme literate doctors in attendance.ECO24: CELLCORE'S biggest event of the...

Read more

FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)

May 16, 2024 8:00 AM

TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), its new packaging and logo of unbuzzd™ expected to launch this summer, an innovative beverage product that is scientifically formulated from a proprietary blend of vitamins, minerals and botanical extracts designed to support the body's natural...

Read more